losartan potassium and hydrochlorothiazide (Unichem Pharmaceuticals (USA), Inc.)
Welcome to the PulseAid listing for the losartan potassium and hydrochlorothiazide drug offered from Unichem Pharmaceuticals (USA), Inc.. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Unichem Pharmaceuticals (USA), Inc. |
| NON-PROPRIETARY NAME: | losartan potassium and hydrochlorothiazide |
| SUBSTANCE NAME: | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-07-21 |
| END MARKETING DATE: | 0000-00-00 |
losartan potassium and hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | losartan potassium and hydrochlorothiazide from Unichem Pharmaceuticals (USA), Inc. |
| LABELER NAME: | Unichem Pharmaceuticals (USA), Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12.5; 50(mg/1; mg/1) |
| START MARKETING DATE: | 2017-07-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 29300-190_4dc2039c-940b-452b-a68c-e5247186f492 |
| PRODUCT NDC: | 29300-190 |
| APPLICATION NUMBER: | ANDA204832 |
Other HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM Pharmaceutical Manufacturers / Labelers:
